Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)
Completed
- Conditions
- COVID-19
- Interventions
- Other: Observational
- Registration Number
- NCT04561193
- Lead Sponsor
- Methodist Health System
- Brief Summary
Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals
- Detailed Description
Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals (Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas) between February 1 and April 30, 2020. All study center utilize Epic ® electronic health record (Verona, Wisconsin; www.epic.com) for which all data will be extracted from.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 417
Inclusion Criteria
- Patients admitted to Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas Medical Centers between February 1, 2020 and April 30, 2020
- >18 years old
- Positive SARS-CoV-2 (COVID-19) PCR test
Exclusion Criteria
- Outpatient or emergency department visit
- Not admitted to an inpatient or observation status for >24 hours
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Retrospective Cohort Observational Patients admitted to Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas Medical Centers between February 1, 2020 and April 30, 2020 with positive COVID-19 PCR test.
- Primary Outcome Measures
Name Time Method Prevalence of subsequent and co-infections Feb 2020 - April 2020 Prevalence of subsequent and co-infections
- Secondary Outcome Measures
Name Time Method Hospital length of stay (LOS) Feb 2020 - April 2020 Hospital length of stay (LOS)
In-hospital mortality Feb 2020 - April 2020 In-hospital mortality
Trial Locations
- Locations (1)
Methodist Dallas Medical Center
🇺🇸Dallas, Texas, United States